arrow
E

Estrella Morenas-Rodríguez

department of neurology, hospital universitario “12 de octubre”, madrid, spain
H指数:36
被引数:5,160

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Severe symptomatic amyloid-related imaging abnormalities in Alzheimer's disease: Two case reports and systematic review of reported cases

症状性严重淀粉样蛋白相关影像异常在阿尔茨海默病中的表现:两例病例报告及已报告病例的系统综述

2025-12-120
PRE
Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study

突触功能障碍和胶质细胞激活标志物在衰老和早期神经退行性病变过程中的变化:一项基于脑脊液生物标志物的纵向研究

2025-10-190
OAAI
Biomarcadores en sangre para la enfermedad de Alzheimer: posicionamiento y recomendaciones de uso del Grupo de Estudio de Conducta y Demencias de la Sociedad Española de Neurología

血液中的阿尔茨海默病生物标志物:西班牙神经病学学会行为与痴呆研究小组的定位和使用建议

2024-11-210
OAAI
TREM2 protects from atherosclerosis by limiting necrotic core formation

TREM2通过限制坏死核心形成来防止动脉粥样硬化

2024-03-126
OAAI
Associations between sex, body mass index and the individual microglial response in Alzheimer's disease
2024-01-235
OAAI
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
2023-07-2613
OAAI
Microglial Activation and Connectivity in Alzheimer Disease and Aging
2022-08-2537
OAAI
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

基因组测序分析确定了与路易体痴呆相关的新基因座,并提供了对其遗传结构的见解

2021-02-15201
OAAI
In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies
2020-11-2736
OAAI
Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
2020-06-0870
OAAI
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019)

PLCG2中的非同义突变降低了阿尔茨海默氏病,路易体痴呆和额颞叶痴呆的风险,并增加了长寿的可能性 (138卷,237页,2019页)

2020-01-180
OAAI
GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (vol 9, 7013, 2019)
2019-10-172
OAAI
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk
2019-08-14177
OAAI
Heritability and genetic variance of dementia with Lewy bodies
2019-07-0123
OAAI
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

PLCG2中的非同义突变可降低阿尔茨海默氏病,路易体痴呆和额颞叶痴呆的风险,并增加长寿的可能性

2019-05-2679
OAAI